Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 2/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 9/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.39 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.39 |
| ▸ | BMP1 | P13497 | 2/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21074906 | 0.87 | PSMB5 (0.46) | PSMB5FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL23289285 | 0.84 | PSMB5 (0.42) | PSMB5FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL25128784 | 0.84 | PSMB5 (0.49) | PSMB5RENCTSDBACE1 | |
| SCHEMBL25129090 | 0.83 | FOLH1 (0.40) | FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL27317088 | 0.82 | PSMB5 (0.42) | PSMB5FOLH1BMP1KEAP1REN | |
| SCHEMBL24622679 | 0.79 | FOLH1 (0.35) | PSMB5FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL17948386 | 0.78 | FOLH1 (0.46) | FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL15846435 | 0.77 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL15846434 | 0.77 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL19681930 | 0.76 | BMP1 (0.39) | FOLH1NAALAD2RIMKLABMP1KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023040793-A1 | ANTI-INFLAMMATORY COMPOUND AND USE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-03-23 | — | — | WO | disclosed |